Estimating The Incidence Of SARS-COV-2 Infections In 2020 In Belgium By Jointly Modelling Seroprevalence, Hospitalization And Mortality Data
Braeye, T.; De Pauw, R.; Geebelen, L.; Abrams, S.; Desombere, I.; Hens, N.; Hammami, N.; Roelants, M.; Herzog, S. A.
Show abstract
BACKGROUNDThe incidence of SARS-CoV-2 infections was not directly observed during the pandemic. We estimated incidences and the associated burden, through the infection fatality rate (IFR) and infection hospitalization rate (IHR), by jointly modeling seroprevalence, hospitalization, and mortality data. METHODSWe used a hierarchical Bayesian model to fit a spline, representing incidence, to the observed number of hospitalizations, deaths and seroprevalence results. Two cross-sectional seroprevalence studies on the prevalence of SARS-CoV-2 antibodies in the general population collected 37,235 samples in the age interval 18 to 74 years across 30 time points between March 2020 and January 2021. One study analyzed residual laboratory samples with the Euroimmun Anti-SARS-CoV-2 ELISA. The other study analyzed blood donor samples with the Wantai Ab ELISA. Data on the sensitivity and specificity of the serological tests were obtained from published research. Time-varying IFR and IHR estimates and their associated delay distributions were estimated within the same model. RESULTSBy the end of January 2021, we estimated 19% (95%CrI 18%-21%), 13% (95%CrI 12%-15%) and 11% (95%CrI 8%-13%) of the Belgian 18-49, 50-64 and 65-74 year-olds to have been infected with SARS-CoV-2. Infections occurred in two large waves with few infections in between. The first wave mostly affected the younger age group, with a peak weekly incidence of 2.0% (95%CrI 1.7%-2.3%) end of March 2020, while weekly incidences were more comparable during the second wave end of October 2020: 1.6% (95%CrI 1.2%-2%) for 65-74 year-olds and 2.8% (95%CrI 2.3%-3.3%) for 18-49 year-olds. Both the hospitalization and fatality rates declined over time. Among persons aged 65 to 74 years the hospitalization rate declined from 9.9% (95%CrI 7.2-13.2) to 5.1% (95%CrI 3.2-6.3) and fatality rates from 2.8% (95%CrI 2.0%-3.8%) to 1.3% (95%CrI 0.9%-1.7%). IHR and IFR were considerably lower in the younger age groups. CONCLUSIONDuring 2020, an estimated 16.2% (95%CrI 15.1%-17.3%) of the Belgian adult population was infected with SARS-CoV-2. These infections occurred primarily in two waves, one in March and another one in October 2020, with minimal transmission in between. Severe disease was more prevalent among older age groups and earlier on in 2020.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Inferring the COVID-19 IFR with a simple Bayesian evidence synthesis of seroprevalence study data and imprecise mortality data 95%
- Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena Valley 95%
- Annual risk of hepatitis E virus infection and seroreversion: insights from a serological cohort in Sitakunda, Bangladesh 94%
Similar papers in this journal
- Estimating the false-negative test probability of SARS-CoV-2 by RT-PCR 95%
- Contact behaviour before, during and after the COVID-19 pandemic in the Netherlands: evidence from contact surveys in 2016-2017 and 2020-2023 95%
- Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period 94%
Similar papers in this journal
- COVID-19 pandemic in Saint Petersburg, Russia: combining surveillance and population-based serological study data in May, 2020–April, 2021 95%
- Key performance indicators of COVID-19 contact tracing in Belgium from September 2020 to December 2021 94%
- Estimating the trend of COVID-19 in Norway by combining multiple surveillance indicators 93%
Similar papers in this journal
- Reconstruction of SARS-CoV-2 outbreaks in a primary school using epidemiological and genomic data 96%
- Estimation of the infection attack rate of mumps in an outbreak among college students using paired serology 94%
- Assessing the effects of non-pharmaceutical interventions on SARS-CoV-2 transmission in Belgium by means of an extended SEIQRD model and public mobility data 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.